CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
DRUG SUSCEPTIBILITY AND BETA-LACTAMASE SUBSTRATE PROFILE OF VIBRIO CHOLERAE NON-01
KAZUHIRO TATEDAKEIZO YAMAGUCHIYOSHIKAZU ISHIIKAZUNORI SHIMOGUCHINOBUCHIKA KUSANOKAZUYUKI SUGAHARATOSHIAKI USUISHIGERU KOHNOKOHEI HARA
Author information
JOURNAL FREE ACCESS

1990 Volume 38 Issue 5 Pages 444-449

Details
Abstract

Vibrio cholerae non-01 are organisms that are biochemically indistinguishable from V.cholerae but do not agglutinate in vibrio group 1 antiserum. Some of these strains have been known to produce a cholera-like toxin and cause dehydrating gastroenteritis in humans. Some reports state that more than 20% of V.cholerae isolated from blood are non-01 especially in patients with liver disease. We investigated drug susceptibility and resistance mechanisms to beta-lactam antibiotics in clinical (10 strains) and environmental isolates (80 strains) of V.cholerae non-01. Of the antibiotics tested, ceftizoxime and ofloxacin were extremely active against V.cholerae non-01: both antibiotics inhibited growth of all strains with 0.025 mg/l. None of the 10 strains of the clinical isolates was resistant to other antibiotics tested. On the other hand, 30 strains of the 80 environmental isolates (37.5%) were resistant to ampicillin (ABPC). All these strains showed MICs of ≥12.5 mg/l and all produced beta-lactamase. In a substrate profile study of this enzyme, it was clarified that the beta-lactamase produced by V.cholerae non-01 was basically penicillinase. There is a possibility thit thus resistance to ABPC in environmental isolates of V.cholerae will spread to clinical isolates. We therefore need to be on our guard against the emergence of resistant strains in clinical V.cholerae non-01 infection.

Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top